Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2025-01-05 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Statement of changes in beneficial ownership of securities 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed pursuant to Section 16(a) of the Securities Exchange Act of 1934. It reports insider transactions, specifically the purchase or sale of company shares by an officer or director. The form includes details such as the name of the reporting person, relationship to the issuer, transaction date, type of security, number of shares disposed of, and price. This type of filing is used to disclose personal share transactions by company directors and executives, which matches the definition of Director's Dealing (DIRS). The document length and content confirm it is not a report or announcement of a report but a specific insider transaction filing.
2025-01-05 English
Statement of changes in beneficial ownership of securities 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by directors, officers, or significant shareholders. The text includes details of a transaction by Peter C. Farrell, a director of ResMed Inc, indicating a sale of shares. This type of filing is specifically related to insider transactions by company directors or executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2025-01-05 English
proposed sale of securities under Rule 144 3 pages 116.6KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider or affiliate, including information about the filer, issuer, securities to be sold, and past sales. This type of filing is specifically related to insider transactions and personal share dealings by company directors or executives. It is not an earnings release, annual report, or any other financial report. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2025-01-02 English
proposed sale of securities under Rule 144 3 pages 121.1KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details insider sales of shares by a director of the company, including dates, amounts, and broker information. This type of filing is specifically related to personal share transactions by company directors and executives, which matches the definition of Director's Dealing (DIRS). The document is not a financial report, earnings release, or regulatory announcement but a specific insider trading notification.
2025-01-02 English
Statement of CDIs on issue - RMD 3 pages 12.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and details the number and class of CHESS Depositary Interests (CDIs) and other securities on issue for ResMed Inc. It includes monthly statements of securities issued, transfers, and changes in securities, referencing ASX codes and stock exchanges. The document is short (3046 characters) and focuses on securities issued and changes in share capital, including share repurchases and employee stock plans. This matches the description of a Share Issue/Capital Change announcement rather than a full financial report or other categories. Therefore, the document is best classified as a Share Issue/Capital Change (SHA).
2025-01-02 English
Statement of changes in beneficial ownership of securities 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as officers, directors, or significant shareholders. The text includes details about a transaction by Brett Sandercock, Chief Financial Officer of ResMed Inc., reporting a sale of shares. This type of filing is specifically related to insider transactions and personal share dealings by company executives. Therefore, the document fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2024-12-11 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.